{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:08:27Z","timestamp":1786727307742,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jconrel.2023.02.043","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T18:29:19Z","timestamp":1678300159000},"page":"288-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy"],"prefix":"10.1016","volume":"356","author":[{"given":"Chen","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-yang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.02.043_bb0005","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0010","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nmat3361","article-title":"Soft fibrin gels promote selection and growth of tumorigenic cells","volume":"11","author":"Liu","year":"2012","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0020","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMra1804280","article-title":"Clinical and therapeutic implications of Cancer stem cells","volume":"380","author":"Clarke","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0030","first-page":"1","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature07567","article-title":"Efficient tumour formation by single human melanoma cells","volume":"456","author":"Quintana","year":"2008","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0040","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07733","article-title":"Association of reactive oxygen species levels and radioresistance in cancer stem cells","volume":"458","author":"Diehn","year":"2009","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2017.09.009","article-title":"MYC and MCL1 cooperatively promote chemotherapy-resistant breast Cancer stem cells via regulation of mitochondrial oxidative phosphorylation","volume":"26","author":"Lee","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2018.06.006","article-title":"Targeting breast cancer stem cell state equilibrium through modulation of redox signaling","volume":"28","author":"Luo","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0055","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0060","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02242","article-title":"Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis","volume":"3","author":"Wheaton","year":"2014","journal-title":"ELife."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0065","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","article-title":"MYC\/PGC-1\u03b1 balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells","volume":"22","author":"Sancho","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0070","article-title":"Phase II clinical trial of metformin as a cancer stem cell\u2013targeting agent in ovarian cancer","volume":"5","author":"Brown","year":"2020","journal-title":"JCI Insight."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0075","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1039\/C9NR01306G","article-title":"Potentiating photodynamic therapy of ICG-loaded nanoparticles by depleting GSH with PEITC","volume":"11","author":"Hu","year":"2019","journal-title":"Nanoscale."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2006.08.009","article-title":"Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by \u03b2-phenylethyl isothiocyanate","volume":"10","author":"Trachootham","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0085","doi-asserted-by":"crossref","first-page":"e2887","DOI":"10.1038\/cddis.2017.272","article-title":"Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ebiom.2018.11.063","article-title":"Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt\/beta-catenin pathway","volume":"39","author":"Li","year":"2019","journal-title":"EBioMedicine."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0095","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.7150\/thno.58655","article-title":"GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy","volume":"11","author":"Mukha","year":"2021","journal-title":"Theranostics."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0100","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41556-019-0407-1","article-title":"CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth","volume":"21","author":"Wang","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121335","article-title":"Leveraging disulfiram to treat cancer: mechanisms of action, delivery strategies, and treatment regimens","volume":"281","author":"Lu","year":"2022","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0110","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature25016","article-title":"Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4","volume":"552","author":"Skrott","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0115","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2011.126","article-title":"Disulfiram modulated ROS\u2013MAPK and NF\u03baB pathways and targeted breast cancer cells with cancer stem cell-like properties","volume":"104","author":"Yip","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0120","doi-asserted-by":"crossref","first-page":"e2797","DOI":"10.1038\/cddis.2017.176","article-title":"Disulfiram\/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-\u03baB and Nrf2","volume":"8","author":"Xu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0125","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/bjc.2013.534","article-title":"Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells","volume":"109","author":"Liu","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084807","article-title":"Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners","volume":"9","author":"Chiba","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0135","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.nano.2016.08.001","article-title":"Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells","volume":"13","author":"Wang","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jb\/mvab045","article-title":"The disulfiram\/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS\/JNK signalling pathway","volume":"170","author":"Guo","year":"2021","journal-title":"J. Biochem. (Tokyo)."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0145","author":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0150","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1016\/j.annonc.2021.05.275","article-title":"Repurposing disulfiram as treatment for metastatic colorectal cancer: an investigator-initiated clinical phase II trial","volume":"32","author":"Tarpgaard","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0155","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/pros.24329","article-title":"Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer","volume":"82","author":"Zhang","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0160","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12885-021-08242-4","article-title":"A phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker","volume":"21","author":"Kelley","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0447.1992.tb03310.x","article-title":"A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites","volume":"86","author":"Johansson","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0170","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.drudis.2020.04.003","article-title":"The combination of disulfiram and copper for cancer treatment","volume":"25","author":"Li","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0175","doi-asserted-by":"crossref","first-page":"1700403","DOI":"10.1002\/adfm.201700403","article-title":"Dual-targeting to cancer cells and M2 macrophages via biomimetic delivery of Mannosylated albumin nanoparticles for drug-resistant Cancer therapy","volume":"27","author":"Zhao","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0180","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1039\/C7SC04853J","article-title":"Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy","volume":"9","author":"Zhao","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0185","article-title":"Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer","volume":"18","author":"Chang","year":"2020","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0190","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jconrel.2020.10.052","article-title":"Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity","volume":"329","author":"Zhao","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0195","doi-asserted-by":"crossref","first-page":"41118","DOI":"10.1021\/acsami.8b14940","article-title":"Disulfiram copper nanoparticles prepared with a stabilized metal ion ligand complex method for treating drug-resistant prostate cancers","volume":"10","author":"Chen","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000207","article-title":"Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery","volume":"8","author":"Zheng","year":"2020","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0205","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1021\/acs.biomac.9b00367","article-title":"Highly stable, coordinated polymeric nanoparticles loading copper(II) Diethyldithiocarbamate for combinational chemo\/chemodynamic therapy of cancer","volume":"20","author":"Peng","year":"2019","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0210","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1021\/acs.molpharmaceut.0c00284","article-title":"Nanoscale copper(II)\u2013Diethyldithiocarbamate coordination polymer as a drug self-delivery system for highly robust and specific Cancer therapy","volume":"17","author":"Peng","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0215","doi-asserted-by":"crossref","first-page":"36894","DOI":"10.1021\/acsami.1c09346","article-title":"Surface decoration via physical interaction of cupric Diethyldithiocarbamate nanocrystals and its impact on biodistribution and tumor targeting","volume":"13","author":"Meng","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/ALN.0b013e3181a7ec82","article-title":"Hydroxyethyl starches: different products \u2013 different effects","volume":"111","author":"Westphal","year":"2009","journal-title":"Anesthesiology."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0225","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1039\/D0RA09663F","article-title":"Hydroxyethyl starch based smart nanomedicine","volume":"11","author":"Wang","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0230","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1039\/C8NA00271A","article-title":"Colloidal hydroxyethyl starch for tumor-targeted platinum delivery","volume":"1","author":"Xiao","year":"2019","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0235","doi-asserted-by":"crossref","first-page":"30833","DOI":"10.1021\/acsami.6b11932","article-title":"Redox-sensitive hydroxyethyl starch\u2013doxorubicin conjugate for tumor targeted drug delivery","volume":"8","author":"Hu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0240","doi-asserted-by":"crossref","first-page":"944","DOI":"10.7150\/thno.67572","article-title":"Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy","volume":"12","author":"Xiong","year":"2022","journal-title":"Theranostics."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0245","doi-asserted-by":"crossref","first-page":"19215","DOI":"10.1021\/acsami.7b04066","article-title":"\u03b1-Amylase- and redox-responsive nanoparticles for tumor-targeted drug delivery","volume":"9","author":"Li","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0250","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1021\/acs.nanolett.9b02769","article-title":"A simple glutathione-responsive turn-on theranostic nanoparticle for dual-modal imaging and chemo-photothermal combination therapy","volume":"19","author":"Li","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0255","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2018.02.026","article-title":"Co-delivery nanoparticle to overcome metastasis promoted by insufficient chemotherapy","volume":"275","author":"Zhou","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121180","article-title":"A novel prodrug and its nanoformulation suppress cancer stem cells by inducing immunogenic cell death and inhibiting indoleamine 2, 3-dioxygenase","volume":"279","author":"Guan","year":"2021","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0265","doi-asserted-by":"crossref","first-page":"10481","DOI":"10.1021\/acsami.7b00048","article-title":"Enhancing doxorubicin delivery toward tumor by hydroxyethyl starch- g -Polylactide partner nanocarriers","volume":"9","author":"Yu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0270","doi-asserted-by":"crossref","first-page":"42225","DOI":"10.1021\/acsami.7b14796","article-title":"Nanocolloidosomes with selective drug release for active tumor-targeted imaging-guided photothermal\/chemo combination therapy","volume":"9","author":"Hu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cej.2018.05.082","article-title":"Hydroxyethyl starch stabilized polydopamine nanoparticles for cancer chemotherapy","volume":"349","author":"Wu","year":"2018","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0280","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1021\/acs.chemrev.6b00636","article-title":"Copper\u2013oxygen complexes revisited: structures, spectroscopy, and reactivity","volume":"117","author":"Elwell","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101248","article-title":"Hyperbaric oxygen regulates tumor microenvironment and boosts commercialized nanomedicine delivery for potent eradication of cancer stem-like cells","volume":"40","author":"Liu","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101458","article-title":"Hyperbaric oxygen regulates tumor mechanics and augments Abraxane and gemcitabine antitumor effects against pancreatic ductal adenocarcinoma by inhibiting cancer-associated fibroblasts","volume":"44","author":"Wang","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0295","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2013.10.029","article-title":"Mechanisms governing metastatic dormancy and reactivation","volume":"155","author":"Giancotti","year":"2013","journal-title":"Cell."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0300","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1039\/D0CS00718H","article-title":"Engineering nanomedicine for glutathione depletion-augmented cancer therapy","volume":"50","author":"Xiong","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0305","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/acs.accounts.1c00635","article-title":"Rational design of nanotherapeutics based on the five features principle for potent elimination of cancer stem cells","volume":"55","author":"Zhang","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0310","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.apsb.2017.09.005","article-title":"Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation","volume":"8","author":"Li","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0315","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0320","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2011.11.031","article-title":"Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers","volume":"159","author":"Wolinsky","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0325","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.redox.2014.11.002","article-title":"Copper\u2013zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma","volume":"4","author":"Salem","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0330","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.biopha.2018.01.109","article-title":"Disulfiram\/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes","volume":"99","author":"Hassani","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0335","doi-asserted-by":"crossref","first-page":"13334","DOI":"10.1039\/C4CC04767B","article-title":"On the interaction of copper(II) with disulfiram","volume":"50","author":"Lewis","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0340","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1039\/c5tx00210a","article-title":"The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells","volume":"4","author":"Tawari","year":"2015","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0345","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2016.02.039","article-title":"Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance","volume":"231","author":"Song","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.741316","article-title":"Recent advances in repurposing disulfiram and disulfiram derivatives as copper-dependent anticancer agents","volume":"8","author":"Kannappan","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.120732","article-title":"Evaluation of the accumulation of disulfiram and its copper complex in A549 cells using mass spectrometry","volume":"211","author":"Lu","year":"2020","journal-title":"Talanta."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0360","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.3390\/ijms22073711","article-title":"Differential cytotoxicity mechanisms of copper complexed with disulfiram in oral cancer cells","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0365","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1248\/bpb.b21-00466","article-title":"Disulfiram chelated with copper promotes apoptosis in osteosarcoma via ROS\/mitochondria pathway","volume":"44","author":"Ren","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0370","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/cancers12010138","article-title":"Disulfiram\/copper induces antitumor activity against both nasopharyngeal cancer cells and cancer-associated fibroblasts through ROS\/MAPK and Ferroptosis pathways","volume":"12","author":"Li","year":"2020","journal-title":"Cancers."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0375","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science."},{"key":"10.1016\/j.jconrel.2023.02.043_bb0380","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2023.02.043_bb0385","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/15384101.2018.1467679","article-title":"Mitostemness","volume":"17","author":"Cuy\u00e0s","year":"2018","journal-title":"Cell Cycle"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923001554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923001554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:38:50Z","timestamp":1759163930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923001554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":77,"alternative-id":["S0168365923001554"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.02.043","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.02.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}